Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis

Authors not listed

Oslo University Hospital · 2026

Abstract

This study investigates whether an advanced MRI technique called Quantitative Susceptibility Mapping (QSM) can improve the differentiation of white matter lesions in people aged 50-70 years with multiple sclerosis (MS). In older individuals with MS, white matter changes seen on MRI may be related to MS or to other types of white matter changes, most commonly age-related changes or chronic small vessel disease. These conditions can appear similar on conventional MRI scans, making interpretation challenging. Participants will undergo routine clinical MRI, including a short additional QSM sequence, as well as brief cognitive and physical assessments. A comparison group with cerebral small vessel disease will also be included. The goal of the study is to determine whether QSM can provide more precise lesion characterization and support more accurate clinical interpretation of MRI findings in older patients with MS.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Anonymous. (2026). Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis. <em>Oslo University Hospital</em>. https://clinicaltrials.gov/study/NCT07444047
Vancouver
Anonymous. Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis. Oslo University Hospital. 2026.
BibTeX
@misc{anon2026Quanti, title = {Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis}, author = {Anonymous}, journal = {Oslo University Hospital}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings